EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nano-Encapsulated Phytosterols Ameliorate Hypercholesterolemia in Mice via Dual Modulation of Cholesterol Metabolism Pathways

Aixia Zhu, Wenjing Pan, Wenjia Jiao, Kai Peng, Chunwei Wang, Chi Zhang, Jiaqi Zhang iD

Nutrients · 2025

DOI: 10.3390/nu17132086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, 2025. Verfasst von Aixia Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan 430023, China. Hauptthemen laut MEDLINE: Phytosterols, Hypercholesterolemia, Cholesterol, Nanoparticles. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Hubei Province Key Laboratory of Animal Nutrition and Feed Science, the Research and Innovation Initiatives of WHPU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The limited bioavailability of free phytosterols restricts their clinical application in managing hypercholesterolemia. This study aimed to develop phytosterol nanoparticles (PNs) to enhance bioactivity and investigate their cholesterol-lowering efficacy and underlying mechanisms in vivo.

Methods

Phytosterol nanoparticles (PNs) (93.35 nm) were engineered using soy protein isolate and administered orally at concentrations of 4.00–12.50 mg/mL to high-fat-diet-induced hypercholesterolemic mice (n = 60) over a 4-week period. Serum and hepatic lipid profiles, histopathology, gene/protein expression related to cholesterol metabolism, and fecal sterol content were evaluated.

Results

PNs dose-dependently reduced serum total cholesterol (TC: 28.6–36.8%), triglycerides (TG: 22.4–30.1%), and LDL-C (31.2–39.5%), while increasing HDL-C by 18.7–23.4% compared to hyperlipidemic controls (p < 0.01). Hepatic TC and TG accumulation decreased by 34.2% and 41.7%, respectively, at the highest dose, with histopathology confirming attenuated fatty degeneration. Mechanistically, PNs simultaneously suppressed cholesterol synthesis through downregulating HMGCR (3.2-fold) and SREBP2 (2.8-fold), while enhancing cholesterol catabolism via CYP7A1 upregulation (2.1-fold) at protein level. Although less potent than simvastatin (p < 0.05), the nanoparticles exhibited unique dual-pathway modulation absent in conventional phytosterol formulations. Fecal analysis revealed dose-responsive cholesterol excretion (36.01 vs. 11.79 mg/g in controls), indicating enhanced enteric elimination. While slightly less potent than simvastatin (p < 0.05), PNs offered unique dual-pathway modulation absent in conventional phytosterol formulations.

Conclusions

Nano-encapsulation significantly improves the bioavailability and hypocholesterolemic efficacy of phytosterols. PNs represent a promising nutraceutical strategy for cholesterol management by concurrently regulating cholesterol synthesis and catabolism, with potential application in both preventive and therapeutic contexts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhytosterolsHypercholesterolemiaCholesterolNanoparticlesAnticholesteremic AgentsAnimalsMiceMaleLiverDiet, High-FatMice, Inbred C57BLTriglyceridesLipid MetabolismFecesDisease Models, Animal

Stichwörter der Autor:innen

CYP7A1cholesterol regulationhigh-fat dietmousephytosterol nanoparticles

Substanzen

PhytosterolsCholesterolAnticholesteremic AgentsTriglycerides

Autor:innen und Institutionen

  • Hubei Key Laboratory of Animal Nutrition and Feed Science, Wuhan Polytechnic University, Wuhan 430023, China.
  • Institute of Animal Science, Guangdong Academy of Agricultural Sciences, Key Laboratory of Animal Nutrition and Feed Science in South China, Ministry of Agriculture and Rural Affairs, Guangdong Provincial Key Laboratory…

ORCID-Profile: Jiaqi Zhang

Förderung

  • National Key R&D Program of China
  • Hubei Province Key Laboratory of Animal Nutrition and Feed Science
  • the Research and Innovation Initiatives of WHPU
  • National Key R&amp;D Program of China
  • Research and Innovation Initiatives of WHPU

Zitieren

APA

Zhu, A., Pan, W., Jiao, W., Peng, K., Wang, C., Zhang, C., & Zhang, J. (2025). Nano-Encapsulated Phytosterols Ameliorate Hypercholesterolemia in Mice via Dual Modulation of Cholesterol Metabolism Pathways. Nutrients. https://doi.org/10.3390/nu17132086

Vancouver

Zhu A, Pan W, Jiao W, Peng K, Wang C, Zhang C, et al. Nano-Encapsulated Phytosterols Ameliorate Hypercholesterolemia in Mice via Dual Modulation of Cholesterol Metabolism Pathways. Nutrients. 2025. doi:10.3390/nu17132086

BibTeX
@article{Zhu2025,
  author = {Zhu, Aixia and Pan, Wenjing and Jiao, Wenjia and Peng, Kai and Wang, Chunwei and Zhang, Chi and Zhang, Jiaqi},
  title = {Nano-Encapsulated Phytosterols Ameliorate Hypercholesterolemia in Mice via Dual Modulation of Cholesterol Metabolism Pathways},
  journal = {Nutrients},
  year = {2025},
  doi = {10.3390/nu17132086}
}
Kostenlos starten →